Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte

Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nephrology 2020-11, Vol.94 (5), p.266-270
Hauptverfasser: Valdés-Lagunes, David A, Méndez-Pérez, R Angélica, de la Cruz, Mercedes Andrea, Uribe-Uribe, Norma O, Mejía-Vilet, Juan M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 270
container_issue 5
container_start_page 266
container_title Clinical nephrology
container_volume 94
creator Valdés-Lagunes, David A
Méndez-Pérez, R Angélica
de la Cruz, Mercedes Andrea
Uribe-Uribe, Norma O
Mejía-Vilet, Juan M
description Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.
doi_str_mv 10.5414/CN110170
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2439631385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610518622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</originalsourceid><addsrcrecordid>eNpdkL1OwzAURj2AaClIPAGyxMISsHMTx2VDUfmRqjJQ5si1b2jaJA62M-TtKdCCxHSXc48-HUIuOLtJE57c5gvOGc_YERkzYDxiCbAROfV-w1jMJMgTMoJYZownckxeF9itnQ2Vpn5ojbMN0qqlYY3UYwhV-05tSeezfBlT1Qy1rYz1lb-jS7VFqmht7Zaq8P3QWWP1EPCMHJeq9ni-vxPy9jBb5k_R_OXxOb-fRxo4D5HJNBgGpTDKaCUyKTDJSpFyTFPQGSgTi6kSwqBOVlOjJKxKwFJrYTjTDGFCrn-8nbMfPfpQNJXXWNeqRdv7Ik5gKoCDTHfo1T90Y3vX7tYVseAs5VLE8Z9QO-u9w7LoXNUoNxScFV9xi0PcHXq5F_arBs0veCgLn6WLdPY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610518622</pqid></control><display><type>article</type><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</creator><creatorcontrib>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</creatorcontrib><description>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</description><identifier>ISSN: 0301-0430</identifier><identifier>DOI: 10.5414/CN110170</identifier><identifier>PMID: 32870148</identifier><language>eng</language><publisher>Germany: Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</publisher><subject>Aged ; Amyloidosis ; Amyloidosis - complications ; Antibodies ; Biopsy ; Cholesterol ; Creatinine ; Edema ; Female ; Humans ; Intercellular Signaling Peptides and Proteins - metabolism ; Kidney - pathology ; Kidney - ultrastructure ; Kidney diseases ; Kidneys ; Male ; Metabolism ; Microscopy ; Nephrology ; Nephrotic Syndrome - etiology ; Nephrotic Syndrome - pathology ; Patients ; Podocytes - pathology ; Proteins ; Remission (Medicine)</subject><ispartof>Clinical nephrology, 2020-11, Vol.94 (5), p.266-270</ispartof><rights>Copyright Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG Nov 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32870148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valdés-Lagunes, David A</creatorcontrib><creatorcontrib>Méndez-Pérez, R Angélica</creatorcontrib><creatorcontrib>de la Cruz, Mercedes Andrea</creatorcontrib><creatorcontrib>Uribe-Uribe, Norma O</creatorcontrib><creatorcontrib>Mejía-Vilet, Juan M</creatorcontrib><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><title>Clinical nephrology</title><addtitle>Clin Nephrol</addtitle><description>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</description><subject>Aged</subject><subject>Amyloidosis</subject><subject>Amyloidosis - complications</subject><subject>Antibodies</subject><subject>Biopsy</subject><subject>Cholesterol</subject><subject>Creatinine</subject><subject>Edema</subject><subject>Female</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney - ultrastructure</subject><subject>Kidney diseases</subject><subject>Kidneys</subject><subject>Male</subject><subject>Metabolism</subject><subject>Microscopy</subject><subject>Nephrology</subject><subject>Nephrotic Syndrome - etiology</subject><subject>Nephrotic Syndrome - pathology</subject><subject>Patients</subject><subject>Podocytes - pathology</subject><subject>Proteins</subject><subject>Remission (Medicine)</subject><issn>0301-0430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkL1OwzAURj2AaClIPAGyxMISsHMTx2VDUfmRqjJQ5si1b2jaJA62M-TtKdCCxHSXc48-HUIuOLtJE57c5gvOGc_YERkzYDxiCbAROfV-w1jMJMgTMoJYZownckxeF9itnQ2Vpn5ojbMN0qqlYY3UYwhV-05tSeezfBlT1Qy1rYz1lb-jS7VFqmht7Zaq8P3QWWP1EPCMHJeq9ni-vxPy9jBb5k_R_OXxOb-fRxo4D5HJNBgGpTDKaCUyKTDJSpFyTFPQGSgTi6kSwqBOVlOjJKxKwFJrYTjTDGFCrn-8nbMfPfpQNJXXWNeqRdv7Ik5gKoCDTHfo1T90Y3vX7tYVseAs5VLE8Z9QO-u9w7LoXNUoNxScFV9xi0PcHXq5F_arBs0veCgLn6WLdPY</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Valdés-Lagunes, David A</creator><creator>Méndez-Pérez, R Angélica</creator><creator>de la Cruz, Mercedes Andrea</creator><creator>Uribe-Uribe, Norma O</creator><creator>Mejía-Vilet, Juan M</creator><general>Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><author>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Amyloidosis</topic><topic>Amyloidosis - complications</topic><topic>Antibodies</topic><topic>Biopsy</topic><topic>Cholesterol</topic><topic>Creatinine</topic><topic>Edema</topic><topic>Female</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney - ultrastructure</topic><topic>Kidney diseases</topic><topic>Kidneys</topic><topic>Male</topic><topic>Metabolism</topic><topic>Microscopy</topic><topic>Nephrology</topic><topic>Nephrotic Syndrome - etiology</topic><topic>Nephrotic Syndrome - pathology</topic><topic>Patients</topic><topic>Podocytes - pathology</topic><topic>Proteins</topic><topic>Remission (Medicine)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valdés-Lagunes, David A</creatorcontrib><creatorcontrib>Méndez-Pérez, R Angélica</creatorcontrib><creatorcontrib>de la Cruz, Mercedes Andrea</creatorcontrib><creatorcontrib>Uribe-Uribe, Norma O</creatorcontrib><creatorcontrib>Mejía-Vilet, Juan M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valdés-Lagunes, David A</au><au>Méndez-Pérez, R Angélica</au><au>de la Cruz, Mercedes Andrea</au><au>Uribe-Uribe, Norma O</au><au>Mejía-Vilet, Juan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</atitle><jtitle>Clinical nephrology</jtitle><addtitle>Clin Nephrol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>94</volume><issue>5</issue><spage>266</spage><epage>270</epage><pages>266-270</pages><issn>0301-0430</issn><abstract>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</abstract><cop>Germany</cop><pub>Dustri - Verlag Dr. Karl Feistle GmbH &amp; Co. KG</pub><pmid>32870148</pmid><doi>10.5414/CN110170</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-0430
ispartof Clinical nephrology, 2020-11, Vol.94 (5), p.266-270
issn 0301-0430
language eng
recordid cdi_proquest_miscellaneous_2439631385
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Amyloidosis
Amyloidosis - complications
Antibodies
Biopsy
Cholesterol
Creatinine
Edema
Female
Humans
Intercellular Signaling Peptides and Proteins - metabolism
Kidney - pathology
Kidney - ultrastructure
Kidney diseases
Kidneys
Male
Metabolism
Microscopy
Nephrology
Nephrotic Syndrome - etiology
Nephrotic Syndrome - pathology
Patients
Podocytes - pathology
Proteins
Remission (Medicine)
title Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T02%3A28%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nephrotic%20syndrome%20in%20the%20setting%20of%20LECT2%20amyloidosis:%20Take%20a%20look%20at%20the%20podocyte&rft.jtitle=Clinical%20nephrology&rft.au=Vald%C3%A9s-Lagunes,%20David%20A&rft.date=2020-11&rft.volume=94&rft.issue=5&rft.spage=266&rft.epage=270&rft.pages=266-270&rft.issn=0301-0430&rft_id=info:doi/10.5414/CN110170&rft_dat=%3Cproquest_cross%3E2610518622%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610518622&rft_id=info:pmid/32870148&rfr_iscdi=true